Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)

Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to auto...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ivan Ivanovich Dedov, Rakhim Musaevich Khaitov, Leonid Petrovich Alexeev
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/705508fe96a2421c890aeda42561fbbe
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:705508fe96a2421c890aeda42561fbbe
record_format dspace
spelling oai:doaj.org-article:705508fe96a2421c890aeda42561fbbe2021-11-14T09:00:20ZImmunity-mediated diseases and human immunogenetics (accomplishments and prospects)2072-03512072-037810.14341/DM7775https://doaj.org/article/705508fe96a2421c890aeda42561fbbe2016-01-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/7775https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to autoimmune diseases. The approach is based on analysis of entire HLA-DRB1 genotypes (not separate HLA-DRB1 haplotypes) of the study participants. Therefore, more effective and personalised classification of T1DM risk groups was achieved by exclusion from significant contingents.Ivan Ivanovich DedovRakhim Musaevich KhaitovLeonid Petrovich AlexeevEndocrinology Research Centrearticletype 1 diabetes mellitusimmunogeneticsimmunity-mediated diseasesNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 19, Iss 1, Pp 8-15 (2016)
institution DOAJ
collection DOAJ
language EN
RU
topic type 1 diabetes mellitus
immunogenetics
immunity-mediated diseases
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle type 1 diabetes mellitus
immunogenetics
immunity-mediated diseases
Nutritional diseases. Deficiency diseases
RC620-627
Ivan Ivanovich Dedov
Rakhim Musaevich Khaitov
Leonid Petrovich Alexeev
Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
description Type 1 diabetes mellitus (T1DM) was used from the viewpoint of human immunogenetics as an example of the most widely studied immunity-mediated disease. This was done in order to develop, approve and implement a new clinical approach to determine immunity-mediated susceptibility or resistance to autoimmune diseases. The approach is based on analysis of entire HLA-DRB1 genotypes (not separate HLA-DRB1 haplotypes) of the study participants. Therefore, more effective and personalised classification of T1DM risk groups was achieved by exclusion from significant contingents.
format article
author Ivan Ivanovich Dedov
Rakhim Musaevich Khaitov
Leonid Petrovich Alexeev
author_facet Ivan Ivanovich Dedov
Rakhim Musaevich Khaitov
Leonid Petrovich Alexeev
author_sort Ivan Ivanovich Dedov
title Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
title_short Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
title_full Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
title_fullStr Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
title_full_unstemmed Immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
title_sort immunity-mediated diseases and human immunogenetics (accomplishments and prospects)
publisher Endocrinology Research Centre
publishDate 2016
url https://doaj.org/article/705508fe96a2421c890aeda42561fbbe
work_keys_str_mv AT ivanivanovichdedov immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects
AT rakhimmusaevichkhaitov immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects
AT leonidpetrovichalexeev immunitymediateddiseasesandhumanimmunogeneticsaccomplishmentsandprospects
_version_ 1718429536858669056